Engineering the perfect (bacterial) cancer therapy
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in certain cases, injection of intratumoral bacteria or their antigens may conversely provide immunostimulatory effects, as demonstrated by Coley’s toxins and recent developments in bacterial cancer therapy (5, 105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
In the citing paper
“BCT is re-gaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“Many treatments, including chemotherapy and radiation, are toxic to normal tissue and cannot completely destroy all cancer cell”
BackgroundTumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Automated design of synthetic ribosome binding sites to control protein expression
Salis, H. M., Mirsky, E. A., & Voigt, C. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1568 · Cited by 1,844
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 715
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“This containment is one possible reason that attenuated Salmonella had limited success in reducing tumour growth in human trial”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563 · cited 1×
“For propulsion and sensing, bacteria have flagella that enable tissue penetratio”
BackgroundCombinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Pfleger, B. F., Pitera, D. J., Smolke, C. D., & Keasling, J. D. (2006) · Nature Biotechnology · doi:10.1038/nbt1226 · Cited by 536 · cited 1×
“, including gene copy number, promoter strength, optimized codons, bacterial metabolism, mRNA secondary structur”
Background
Cited by
Items 401–500 of 905
Becerra-Báez, E. I., Meza-Toledo, S. E., Muñoz-López, P., Flores-Martínez, L. F., Fraga-Pérez, K., Magaño-Bocanegra, K. J., Juárez-Hernández, U., Mateos-Chávez, A. A., & Luría-Pérez, R. (2022) · Cancers · doi:10.3390/cancers14174224 · Cited by 24
“The tumor microenvironment is characteristically hypoxic (≤10 mmHg) [50], acidic [10], necrotic [10], and one in which the immune response is suppressed [5], but favoring the selectivity and permanence of Salmonella enterica within the tumor microenvironment [10].”
BackgroundInfluentialCurrent advances in bacteria‐based cancer immunotherapy
Guo, C., Liu, J., & Zhang, Y. (2023) · European Journal of Immunology · doi:10.1002/eji.202350778 · Cited by 23
Lipid A controls the robustness of intratumoral accumulation of attenuated Salmonella in mice
Zhang, M., Swofford, C. A., & Forbes, N. S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28700 · Cited by 28
Self-citationBottom-up approaches in synthetic biology and biomaterials for tissue engineering applications
Weisenberger, M. S., & Deans, T. L. (2018) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-018-2027-3 · Cited by 23
Kwon, S., Jiang, S., Zheng, J. H., Choy, H. E., & Min, J. (2014) · Microbiology and Immunology · doi:10.1111/1348-0421.12134 · Cited by 22
“The tumor-targeting mechanisms of bacteria are not well understood; however, they may differ depending on oxygen tolerance (19).”
BackgroundShen, C., Li, Y., Zeng, Z., Liu, Y., Xu, Y., Deng, K., Guo, B., Zou, D., Liu, L., Liang, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c10302 · Cited by 22
Bo, Y., Wang, H., Niu, H., He, X., Xue, Q., Li, Z., Yang, H. C., & Niu, F. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1327441 · Cited by 23
“Exploiting bacterial taxis and extracellular responses enables precise drug release in tumor microenvironments for cancers like hepatocellular carcinoma, colorectal cancer, and prostate cancer (Forbes, 2010).”
BackgroundDai, T., Ye, F., Hu, P., Pan, X., Chen, J., Huang, Y., Wang, H., Zhang, L., Huang, M., Liu, J., et al. (2020) · Science China Materials · doi:10.1007/s40843-020-1363-2 · Cited by 21
Actuators for Implantable Devices: A Broad View
Yan, B. (2022) · Micromachines · doi:10.3390/mi13101756 · Cited by 23
“[143] In this setting, attenuated strains of flagellar bacteria have unique advantages in delivering cancer therapies because they can specifically target and proliferate in tumors [144,145].”
BackgroundEngineering and control of biological systems: A new way to tackle complex diseases
Menolascina, F., Siciliano, V., & di Bernardo, D. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.050 · Cited by 25
“1a (see [14] for a review).”
Choe, E. Y., Kazmierczak, R. A., & Eisenstark, A. (2014) · mBio · doi:10.1128/mbio.01182-14 · Cited by 24
“reasons outlined in published reports (4, 5), these findings have”
BackgroundShi, L., Yu, B., Cai, C., Huang, W., Zheng, B., Smith, D. K., & Huang, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.005 · Cited by 22
“However, to date, clinical trials of bacterial mediated therapy have had modest results [5, 16].”
BackgroundA Secretion-Amplification Role for Salmonella enterica Translocon Protein SipD
Glasgow, A. A., Wong, H. T., & Tullman‐Ercek, D. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00335 · Cited by 21
Metabolic reprogramming of tumor microenviroment by engineered bacteria
Wang, H., Xu, F., & Wang, C. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.003 · Cited by 24
Recent advances of engineered probiotics for therapeutic applications
Zhang, L., Chen, N., Chen, H., Tang, C., Wang, J., Wang, Y., Zhang, Y., Guo, H., & Yuan, J. (2025) · BioDesign Research · doi:10.1016/j.bidere.2025.100039 · Cited by 32
“As early as 2010, Forbes et al. summarized the use of genetically edited bacteria for treating cancer [11].”
Iwata, S., Nishiyama, T., Sakari, M., Doi, Y., Takaya, N., Ogitani, Y., Nagano, H., Fukuchi, K., & Miyako, E. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01459-9 · Cited by 26
“11 and 12).”
Jameel, M., & Kwok, H. F. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.011 · Cited by 22
Prospects and applications of synergistic noble metal nanoparticle-bacterial hybrid systems
Vázquez‐Arias, A., Pérez‐Juste, J., Pastoriza‐Santos, I., & Bodelón, G. (2021) · Nanoscale · doi:10.1039/d1nr04961e · Cited by 19
Tumor-isolated Cutibacterium acnes as an effective tumor suppressive living drug
Chintalapati, S. S. V. V., Iwata, S., Miyahara, M., & Miyako, E. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116041 · Cited by 22
Bacteria-Based Nanoprobes for Cancer Therapy
Lu, Y., Mei, N., Ying, Y., Wang, D., Li, X., Zhao, Y., Zhu, Y., Shen, S., & Yin, B. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s438164 · Cited by 22
“33,34 The hypoxia status of a tumor leads to resistance to cytotoxic agents and radiation, and finally brings poor prognosis.”
BackgroundWang, W., Song, J., Yu, W., Chen, M., Li, G., Chen, J., Chen, L., Yu, L., & Chen, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202400929 · Cited by 20
Improved cytotoxic effects of S almonella ‐producing cytosine deaminase in tumour cells
Mesa‐Pereira, B., Medina, C., Camacho, E. M., Flores, A., & Santero, E. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12153 · Cited by 23
“Over the past decade, many genera of bacteria have been explored as cell factories for cancer therapy due to their ability to specifically target tumours (Pawelek et al., 1997), reviewed in (Forbes, 2010).”
BackgroundSeo, I., Jha, B. K., Suh, S., Suh, M., & Baek, W. (2014) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2014.44.2.162 · Cited by 21
“Clostridium increases significantly as gastric pH increases (11), and Clostridium preferentially accumulates in tumors (33).”
BackgroundProteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model
Zhang, H., Diao, H., Jia, L., Yuan, Y., Thamm, D. H., Wang, H., Jin, Y., Pei, S., Zhou, B., Yu, F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188960 · Cited by 23
Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy
Wang, C., Wen, D., & Gu, Z. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00619 · Cited by 19
RETRACTED: Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus Lactis
Garza-Morales, R., Rendon, B. E., Malik, M. T., Garza-Cabrales, J. E., Aucouturier, A., Bermúdez‐Humarán, L. G., McMasters, K. M., McNally, L. R., & Gómez-Gutiérrez, J. G. (2020) · Cancers · doi:10.3390/cancers12020438 · Cited by 20
“9 the unique tumor colonizing ability of bacteria [42,43].”
BackgroundRetractedKhodavirdipour, A., Jamshidi, F., Nejad, H. R., Zandi, M., & Zarean, R. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00433-9 · Cited by 21
Back to the Future: Are Tumor-Targeting Bacteria the Next-Generation Cancer Therapy?
Hoffman, R. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2727-2_14 · Cited by 20
Clinical Translation of Inorganic Nanoparticles and Engineered Living Materials for Cancer Therapy
Gandarias, L., & Faivre, D. (2024) · ChemPlusChem · doi:10.1002/cplu.202400090 · Cited by 20
Modulating gut microbiota using nanotechnology to increase anticancer efficacy of the treatments
Jalil, A. T., Thabit, S. N., Hanan, Z. K., Alasheqi, M. Q., Al-Azzawi, A. K. J., Zabibah, R. S., & Fadhil, A. A. (2023) · Macromolecular Research · doi:10.1007/s13233-023-00168-z · Cited by 20
The role of extratumoral and intratumoral microorganisms in cancer immunotherapy
Du, Y., Liu, L., Ma, W., Yan, W., Mao, W., Du, Y., Cui, K., Pu, Y., Li, Z., Sansonetti, P. J., et al. (2023) · The Innovation Life · doi:10.59717/j.xinn-life.2023.100016 · Cited by 21
Treating cancer with infection: a review on bacterial cancer therapy
Wong, S. L., & Slavcev, R. A. (2015) · Letters in Applied Microbiology · doi:10.1111/lam.12436 · Cited by 19
“Anaerobic bacteria are demonstratively well-suited as natural anticancer agents due to their intrinsic cytotoxicity, motility, tumour specificity and capacity for therapeutic gene expression (Malmgren and Flanigan 1955; Forbes 2010).”
BackgroundRodrigues, J. L., Ferreira, D., & Rodrigues, L. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100741-9.00016-4 · Cited by 19
Hoffman, R. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0227 · Cited by 19
“Recently, there has been intense interest to develop bacterial therapy of cancer using modern methods of bacterial genetics, cancer cell and molecular biology, and in vivo imaging (2, 3).”
Ma, X., Liu, P., Tian, Y., Zhu, G., Yang, P. H., Wang, G., & Yang, L. (2018) · Nanoscale · doi:10.1039/c7nr07714a · Cited by 19
Anticancer Natural Products: A Review
Elrayess, R. A., & El-Hak, H. N. G. (2019) · Cancer Studies and Molecular Medicine - Open Journal · doi:10.17140/csmmoj-5-127 · Cited by 19
Liu, L., Wu, J., Gao, J., & Lu, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000893 · Cited by 18
Wu, Y., Li, Q., Liu, Y., Li, Y., Chen, Y., Wu, X., & Liu, X. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120817 · Cited by 21
Engineering Cell‐Based Systems for Smart Cancer Therapy
Mirkhani, N., Gwisai, T., & Schuerle, S. (2021) · Advanced Intelligent Systems · doi:10.1002/aisy.202100134 · Cited by 18
Quantitative Investigation of the Role of Intra-/Intercellular Dynamics in Bacterial Quorum Sensing
Leaman, E. J., Geuther, B. Q., & Behkam, B. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00406 · Cited by 19
Totter, E., von Einsiedel, E., Regazzoni, L., & Schuerle, S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115577 · Cited by 20
Nagaraju, B., Patil, Y. P., Ekghara, S. D., Patil, K. S., & Bonthu, M. G. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.08.004 · Cited by 31
Carter, K. K., Valdés, J. J., & Bentley, W. E. (2011) · Metabolic Engineering · doi:10.1016/j.ymben.2011.11.006 · Cited by 23
Chan-Hyams, J. V. E., Copp, J. N., Smaill, J. B., Patterson, A. V., & Ackerley, D. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.020 · Cited by 18
“However, studying the e ff ects of prodrug activation by bacterial activator cells in co-culture with target carcinoma cells would be confounded by the naturally oncolytic nature of bacteria, which would cause death of the target cells by numerous prodrug-independent mechanisms [11,23].”
BackgroundInfluentialBacterial infections in cancer: A bilateral relationship
Basu, A., Singh, R., & Gupta, S. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1771 · Cited by 21
Bacteria-mediated tumor immunotherapy via photothermally-programmed PD1 expression
Xu, W., Ren, D., Yu, Z., Hou, J., Huang, F., Gan, T., Ji, P., Zhang, C., Ma, L., & Hu, Y. (2022) · Nanoscale Advances · doi:10.1039/d1na00857a · Cited by 19
Engineered Bacteria: General Overview as Therapeutic Agent and a Novel Drug Delivery System
Patil, P. L., Gharat, S. K., Jadhav, K. R., & Kadam, V. J. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666221220113517 · Cited by 18
Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?
Goubet, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1185163 · Cited by 19
“) that act as chemoattractants for bacteria (20, 21).”
BackgroundHenkel, S. G., Beek, A. T., Steinsiek, S., Stagge, S., Bettenbrock, K., de Mattos, M. J. T., Sauter, T., Sawodny, O., & Ederer, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107640 · Cited by 24
“host-pathogeninteraction or cancer therapy), see also for example [55–58].”
Modular Design of a Synthetic Payload Delivery Device
Huh, J. H., Kittleson, J. T., Arkin, A. P., & Anderson, J. C. (2013) · ACS Synthetic Biology · doi:10.1021/sb300107h · Cited by 18
Biomimetic Salmonella: A Next-Generation Therapeutic Vector?
Felgner, S., Kocijancic, D., Pawar, V., & Weiß, S. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.08.007 · Cited by 18
Hauk, P., Stephens, K., Virgile, C., VanArsdale, E. S., Pottash, A. E., Schardt, J. S., Jay, S. M., Sintim, H. O., & Bentley, W. E. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00179 · Cited by 19
A Comprehensive Review on the Anticancer Potential of Bacteriocin: Preclinical and Clinical Studies
Goh, K. S., Ng, Z. J., Halim, M., Oslan, S. N., Oslan, S. N. H., & Tan, J. S. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10386-1 · Cited by 22
“According to Forbes (2010), few problems in combining chemotherapy with bacteriotherapy have been identified, this including inaccurate tumor targeting, inadequate tissue penetration and limited toxicity to cancer cells.”
BackgroundNanoparticles induced cuproptosis to enhance antitumor immunotherapy
Deng, W., Zhong, Z., Shang, H., Tong, Y., Huang, Q., Yu, H., Wu, J., Ba, X., Chen, Z., Chen, Y., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03616-3 · Cited by 23
“Ruan et al. have highlight the unique ability of certain anaerobic bacteria [142], like Salmonella and Escherichia coli (E. coli), to colonize solid tumors, offering a paradigm-shifting approach for targeted tumor therapy [143, 144].”
Niu, L., Deng, Z., Jin, Y., Guan, N., & Ye, H. (2025) · Protein & Cell · doi:10.1093/procel/pwaf085 · Cited by 29
Genetic Programming by Nitric Oxide-Sensing Gene Switch System in Tumor-Targeting Bacteria
Qin, Y., You, S.-H., Zhang, Y., Venu, A., Hong, Y., & Min, J. (2023) · Biosensors · doi:10.3390/bios13020266 · Cited by 22
“∆ppGpp) showed tumor: normal organ bacterial ratio of over 10,000:1, with bacterial cells reaching 1 × 107 CFU/g in tumor 3 days after intravenous injection [8,9], and cause various anticancer immune responses, including recruiting immune cells and secretion of proinflammatory cytokines, such as IFN-γ, TNF-α, and IL-1…”
BackgroundCancer immunotheranostics using bioactive nanocoated photosynthetic bacterial complexes
Reghu, S., Iwata, S., Komatsu, S., Nakajo, T., & Miyako, E. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101966 · Cited by 20
Liu, S., Liu, Z., Lei, H., Miao, Y., & Chen, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403019 · Cited by 18
Zhang, X., Zang, Z., Liang, Z., Xu, X., Zheng, J., Liang, N., Shabiti, S., Wang, Z., Yu, S., Wang, Y., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c16740 · Cited by 20
Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Yang, M., Zhong, P., & Wei, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052056 · Cited by 18
“Bacteria, due to their ability to preferentially grow in the hypoxic and necrotic regions of the tumor microenvironment, represent a promising vehicle for delivering a variety of compounds directly to tumors, thereby inducing an immune response in situ [64].”
Chloroquine enhanced the anticancer capacity of VNP20009 by inhibiting autophagy
Zhang, X., Xu, Q., Zhang, Z., Cheng, W., Cao, W., Jiang, C., Han, C., Li, J., & Hua, Z. (2016) · Scientific Reports · doi:10.1038/srep29774 · Cited by 18
“When the tumor was palpable, the animals were treated with: (1) PBS, (2) VNP20009, (3) chloroquine, and (4) chloroquine plus VNP20009.”
Attenuated Salmonella typhimurium -mediated tumour targeting imaging based on peptides
Xiong, S., Qi, Z., Ni, J., Zhong, J., Cao, L., & Yang, K. (2020) · Biomaterials Science · doi:10.1039/d0bm00013b · Cited by 17
Safarpour-Dehkordi, M., Doosti, A., & Jami, M. (2020) · PubMed Central · doi:10.22074/cellj.2020.6996 · Cited by 18
“Bacterial toxins are used to induce apoptosis during infection and they are presently considered to be important in disease processes (16, 27).”
BackgroundModeling of chemotactic steering of bacteria-based microrobot using a population-scale approach
Cho, S., Choi, Y. J., Zheng, S., Han, J., Ko, S. Y., Park, J., & Park, S. (2015) · Biomicrofluidics · doi:10.1063/1.4932304 · Cited by 17
Murakami, T., Hiroshima, Y., Zhao, M. D., Zhang, Y., Chishima, T., Tanaka, K., Bouvet, M., Endo, I., & Hoffman, R. M. (2015) · Oncotarget · doi:10.18632/oncotarget.5187 · Cited by 17
“com/oncotarget Bacteria have numerous advantages over other biological therapy in that bacteria actively invade tumors, even when vascularity is poor and have a large genome to manipulate for effective and selective tumor targeting [2].”
BackgroundDevelopment of a genetic sensor that eliminates p53 deficient cells
Mircetic, J., Dietrich, A., Paszkowski‐Rogacz, M., Krause, M., & Buchholz, F. (2017) · Nature Communications · doi:10.1038/s41467-017-01688-w · Cited by 18
Efficient tumor targeting by anaerobic butyrate-producing bacteria
Tirandaz, H., & Mohammadi, E. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.01.024 · Cited by 17
“Introducing some genes that previously used in bacterial tumor targeting [6,7,34,41] into selected high butyrate-producing strains and using these strains in combination bacteriolytic therapy (COBALT) strategy [37] and/or in combination with novel clinically applicable strategies may synergistically enhance the abilit…”
BackgroundA revisit to universal single-copy genes in bacterial genomes
Wang, S., Ventolero, M. F. H., Hu, H., & Li, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-18762-z · Cited by 19
“microbial diversity, and the cure of various complex diseases [19-24].”
BackgroundSetting “cold” tumors on fire: Cancer therapy with live tumor-targeting bacteria
Manole, S., Nguyen, D.-H., Min, J.-J., Zhou, S., & Forbes, N. (2024) · Med · doi:10.1016/j.medj.2024.11.002 · Cited by 20
Self-citationChauchet, X., Hannani, D., Djebali, S., Laurin, D., Polack, B., Marvel, J., Buffat, L., Toussaint, B., & Gouëllec, A. L. (2016) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2016.33 · Cited by 16
Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines
Ladaycia, A., Loretz, B., Passirani, C., Lehr, C., & Lepeltier, É. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.015 · Cited by 17
Effect of Salmonella treatment on an implanted tumor (CT26) in a mouse model
Yun, M., Pan, S., Jiang, S., Nguyen, V. H., Park, S., Jung, C., Kim, H.-S., Min, J., Choy, H. E., & Hong, Y. (2012) · The Journal of Microbiology · doi:10.1007/s12275-012-2090-9 · Cited by 16
“Caulobacter, Listeria, Proteus, and Streptococcus (reviewed in Forbes, 2010).”
Increasing the bactofection capacity of a mammalian expression vector by removal of the f1 ori
Johnson, S. A., Ormsby, M. J., McIntosh, A., Tait, S. W. G., Blyth, K., & Wall, D. M. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0039-9 · Cited by 17
Taniguchi, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060566 · Cited by 17
Akbariqomi, M., Zarandi, P. K., Abedi, A., Moghaddam, M. M., & Fooladi, A. A. I. (2025) · Microbial Cell Factories · doi:10.1186/s12934-025-02838-2 · Cited by 17
“In contrast, the TME significantly suppresses the immune response, hindering the eradication of microorganisms [44, 45].”
Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?
Mowday, A. M., van de Laak, J., Fu, Z., Henare, K. L., Dubois, L. J., Lambin, P., Theys, J., & Patterson, A. V. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2311653 · Cited by 19
“…accumulate and proliferate preferentially within solid tumors using a variety of unique mechanisms (discussed in detail by Morrissey et al. 2010 and Forbes 2010). in general, the initial number of bacteria delivered to normal and tumor tissue is similar, but bacteria in the circulation and/or…”
BackgroundKhanduja, S., Bloom, S. M. K., Raman, V., Deshpande, C. P., Hall, C. L., & Forbes, N. S. (2024) · iScience · doi:10.1016/j.isci.2024.109813 · Cited by 15
Self-citationMicrobiome's Universe: Impact on health, disease and cancer treatment
Réthi‐Nagy, Z., & Juhász, S. (2024) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2024.07.002 · Cited by 18
Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella
Kim, K., Min, S.-Y., Lim, H.-D., You, S.-H., Lim, D., Jeong, J., Kim, H., Rhee, J. H., Park, K., Shin, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24013 · Cited by 19
“This accumulation of Salmonella is due in part to the immune-suppressive environment in tumor tissue, which allows proliferation of intratumoral Salmonella to densities greater than 109 colony-forming units (CFU)/g of tissue [40, 41].”
BackgroundMateos-Chávez, A. A., Muñoz-López, P., Becerra-Báez, E. I., Flores-Martínez, L. F., Prada‐Gracia, D., Moreno‐Vargas, L. M., Baay-Guzman, G. J., Juárez-Hernández, U., Chávez‐Munguía, B., Cabrera-Muñóz, L., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02562 · Cited by 15
Lim, D., Jung, W. C., Jeong, J., & Song, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00840 · Cited by 17
“coli carrying a protein with no anti-tumor activity (Min et al., 2008; Forbes, 2010; Van Dessel et al., 2015).”
BackgroundInfluentialCoating bacteria for anti-tumor therapy
Wang, J., Guo, N., Hou, W., & Qin, H. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1020020 · Cited by 17
“The non-pathogenic parthenogenic anaerobic bacterium Salmonella can specifically target tumor sites to regulate immune response (Pawelek et al., 1997; Lee et al., 2005; Zhao et al., 2005; Forbes, 2010; Chang and Lee, 2014).”
BackgroundMurakami, T., Hiroshima, Y., Zhao, M. D., Zhang, Y., Chishima, T., Tanaka, K., Bouvet, M., Endo, I., & Hoffman, R. M. (2015) · Oncotarget · doi:10.18632/oncotarget.6170 · Cited by 15
“Bacterial therapy of cancer has a long history [3-5].”
BackgroundYue, L., Geng, F., Jin, J., Li, W., Liu, B., Du, M., Gao, X., Lü, J., & Pan, X. (2024) · Biotechnology Journal · doi:10.1002/biot.202400428 · Cited by 14
“…coli target the tumor microenvironment through complex mechanisms, such as trapping in the chaotic tumor vasculature following systemic injection, tropism for compounds produced by tumors, tumor localization following inflammation, and protection from clearance by the immune system [7–9].”
InfluentialLi, J., Yang, R., Yuan, Y., Ren, H., Fang, C., Lovell, J. F., & Zhang, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202414994 · Cited by 17
Deciphering novel enzymatic and non-enzymatic lysine lactylation in Salmonella
Zhang, C.-Z., Zhou, T., Li, C., Wang, D., Jing, T., Zhu, X., Lu, J. L., Ni, J., & Yao, Y. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2475838 · Cited by 16
“Live Salmonella are employed in cancer treatment due to their unique roles in inducing tumour cell lysis, cytokine secretion, and antitumour responses [52,53].”
Recent Advances in Spatiotemporal Manipulation of Engineered Bacteria for Precision Cancer Therapy
Chang, X., Liu, X., Wang, X., Ma, L., Liang, J., & Li, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s516523 · Cited by 14
“7,8 Thus, to boost the effectiveness of cancer treatments while reducing adverse reactions, it is essential to fine-tune bacteria for accurate and on-demand medication delivery directly to the tumour location.”
The multi-kingdom cancer microbiome
Dohlman, A. B., Pan, X., Zitvogel, L., & Iliev, I. D. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02103-7 · Cited by 18
“Bacteria engineered to target the tumour site and provoke an antitumour immune response or deliver therapeutic payloads have also gained interest 148–150 .”
Qin, S., Wang, Q., Zhang, Z., Gu, J., He, G., Zeng, F., Chen, R., He, B., Wang, Y., Wang, M., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c10242 · Cited by 15
Rectification of Bacterial Diffusion in Microfluidic Labyrinths
Weber, A., Bahrs, M., Alirezaeizanjani, Z., Zhang, X., Beta, C., & Zaburdaev, V. (2019) · Frontiers in Physics · doi:10.3389/fphy.2019.00148 · Cited by 15
Salmonella alters heparanase expression and reduces tumor metastasis
Chiu, H.-M., Chiou, W., Hsu, W.-J., Wu, L.-H., Yang, M.-H., Tyan, Y., & Lee, C. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.60281 · Cited by 14
“Researchers have found Salmonella to possess tumor-targeting potential and considered Salmonella to be new strategies in the treatment of tumors [25, 26].”
BackgroundSalmonella typhimurium may support cancer treatment: a review
Yang, Z., Zou, L., Yue, B., & Hu, M. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023007 · Cited by 17
“Nutritional deficiency and bacterial toxin release may promote apoptosis [27,28].”
BackgroundDynamic interplay of intratumoral microbiota within the colorectal cancer microenvironment
Wu, Y., Wang, P., Zhao, X., Liu, T., Situ, B., & Zheng, L. (2023) · View · doi:10.1002/viw.20230100 · Cited by 15
Engineered oncolytic bacteria for malignant solid tumor treatment
Wang, M., Song, X., Liu, X., Ma, C., Ma, J., & Shi, L. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240005 · Cited by 18
A Light‐Driven Anti‐Cancer Dual‐Therapeutic Cassette Enhances Solid Tumour Regression
Kim, A. R., Shin, S. W., Cho, S., Lee, J. Y., Kim, D., & Um, S. H. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200471 · Cited by 14
The potential roles of bacteria to improve radiation treatment outcome
Kouhsari, E., Ghadimi‐Daresajini, A., Abdollahi, H., Amirmozafari, N., Mahdavi, S. R., Abbasian, S., Mousavi, S. H., Yaseri, H. F., & Moghaderi, M. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1701-7 · Cited by 15
Menghini, S., Ho, P. S., Gwisai, T., & Schuerle, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020498 · Cited by 14
“Colonizing bacteria can also engage in nutrient competition within the tumor 58 microenvironment [8-10].”
BackgroundMackie, G. M., Copland, A., Takahashi, M., Nakanishi, Y., Everard, I., Kato, T., Oda, H., Kanaya, T., Ohno, H., & Maslowski, K. M. (2021) · JCI Insight · doi:10.1172/jci.insight.139900 · Cited by 19
“Therefore, there has been a resurgence in interest in BCT in the past 20 years, with many studies showing efficacy of attenuated bacterial treatments in xenograft and orthotopic transplant tumor models, with Salmonella enterica serovar Typhimurium ( S Tm) being by far the most studied (3–9).”
Williams, E. M., Rich, M. H., Mowday, A. M., Ashoorzadeh, A., Copp, J. N., Guise, C. P., Anderson, R. F., Flanagan, J. U., Smaill, J. B., Patterson, A. V., et al. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00376 · Cited by 14
Shirai, H., & Tsukada, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.024 · Cited by 15
Metadata
- Authors
- Forbes, N. S.
- Affiliations
- University of Massachusetts Amherst (US)
- Corresponding author
- Forbes, Neil S.
- ORCID
- Forbes, Neil S.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-14
- Volume
- 10
- Issue
- 11
- Pages
- 785-794
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3756932
- OpenAlex
- W1979507175
- Cited by
- 905
- References
- 141
- Citations by year
- 2026: 76 · 2025: 89 · 2024: 95 · 2023: 76 · 2022: 81 · 2021: 81 · 2020: 69 · 2019: 47 · 2018: 47 · 2017: 46 · 2016: 42 · 2015: 40 · 2014: 45 · 2013: 37 · 2012: 20
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA120825, CA120825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial cancer therapy, synthetic biology, Salmonella, Clostridium, tumor targeting, bacterial cytotoxicity, bacterial stability, bacterial toxicity, tumor growth control, cancer immunotherapy
- MeSH terms
- Animals, Antineoplastic Agents, Clostridium, Genetic Engineering, Humans, Neoplasms, Salmonella
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.